Early intubation and restrictive fluid management are key in the treatment of patients with moderate-severe COVID-19 pneumonitis

被引:0
|
作者
Ballin, Andrea [1 ]
Bonvicini, Daniele [1 ]
Vasques, Francesco [2 ,3 ]
Bond, Ottavia [1 ]
Tiberio, Ivo [1 ]
机构
[1] Univ Hosp Padua, Dept Urgency & Emergency, Unit Anesthesiol & Intens Care, Via Giustiniani 2, I-35127 Padua, Italy
[2] Kings Hlth Partners, Dept Adult Crit Care, Guys & St Thomas NHS Fdn Trust, London, England
[3] St Thomas Hosp, London, England
关键词
D O I
10.23736/S0375-9393.20.14961-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:1250 / 1252
页数:4
相关论文
共 50 条
  • [1] Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
    Mastroianni, Antonio
    Vangeli, Valeria
    Chidichimo, Luciana
    Urso, Filippo
    De Marco, Giuseppe
    Zanolini, Alfredo
    Greco, Francesca
    Mauro, Maria, V
    Greco, Sonia
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2023, 37
  • [2] Remdesivir treatment for patients with moderate to severe COVID-19
    Hasanoglu, Imran
    Guner, Rahmet
    Celik, Ilhami
    Kanat, Fikret
    Batirel, Ayse
    Dizman, Gulcin Telli
    Eren, Esma
    Sevgi, Dilek Yildiz
    Bozkurt, Ilkay
    Yasar, Kadriye Kart
    Senoglu, Sevtap
    Kazak, Esra
    Karaali, Ridvan
    Celikbas, Aysel
    Pullukcu, Husnu
    Cagatay, Arif Atahan
    Unal, Serhat
    Erdinc, Sebnem
    Tabak, Fehmi
    Gul, Ahmet
    Alp, Emine
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 880 - 887
  • [3] Co-infections and antimicrobial use in hospitalized patients with moderate-severe COVID-19
    Frederiksen, L.
    Subedi, S.
    Choong, K.
    Anderson, J.
    Baird, T.
    [J]. RESPIROLOGY, 2023, 28 : 106 - 106
  • [4] Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
    Ma, Aijia
    Cheng, Jiangli
    Yang, Jing
    Dong, Meiling
    Liao, Xuelian
    Kang, Yan
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [5] Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients
    Aijia Ma
    Jiangli Cheng
    Jing Yang
    Meiling Dong
    Xuelian Liao
    Yan Kang
    [J]. Critical Care, 24
  • [6] Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
    V. Spagnuolo
    M. Guffanti
    L. Galli
    A. Poli
    P. Rovere Querini
    M. Ripa
    M. Clementi
    P. Scarpellini
    A. Lazzarin
    M. Tresoldi
    L. Dagna
    A. Zangrillo
    F. Ciceri
    A. Castagna
    [J]. Scientific Reports, 10
  • [7] Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
    Spagnuolo, V
    Guffanti, M.
    Galli, L.
    Poli, A.
    Querini, P. Rovere
    Ripa, M.
    Clementi, M.
    Scarpellini, P.
    Lazzarin, A.
    Tresoldi, M.
    Dagna, L.
    Zangrillo, A.
    Ciceri, F.
    Castagna, A.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [8] The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients
    Aliska, Gestina
    Nafrialdi, Nafrialdi
    Lie, Khie Chen
    Setiabudy, Rianto
    Putra, Andani Eka
    Widyahening, Indah Suci
    Harahap, Alida Roswita
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 943
  • [9] Use of sildenafil in patients with severe COVID-19 pneumonitis
    McFadyen, Charles
    Garfield, Ben
    Mancio, Jennifer
    Ridge, Carole A.
    Semple, Tom
    Keeling, Archie
    Ledot, Stephane
    Patel, Brijesh
    Samaranayake, Chinthaka B.
    McCabe, Colm
    Wort, S. John
    Price, Susanna
    Price, Laura C.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2022, 129 (01) : E18 - E21
  • [10] ABCD Mnemonic in moderate to severe COVID-19 management
    Ahuja, Vanita
    Mahajan, Aastika
    Bevoor, Arun A.
    [J]. JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2022, 38 : 153 - 154